Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: equivalent (308), identical (15), alike (9), different (1000), total (433), equate (33)

Gemcitabine-Paclitaxel Albumin Bound (Abraxane)

Description: Chemotherapy Protocol PANCREATIC CANCER GEMCITABINE-PACLITAXEL ALBUMIN BOUND Regimen • Pancreatic Cancer – Gemcitabine-Paclitaxel Albumin Bound In
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Gemcitabine-Paclitaxel-Albumin-Bound-Abraxane-Ver2.pdf

Atezolizumab-Paclitaxel Albumin Bound

Description: Chemotherapy Protocol BREAST CANCER Atezolizumab-Paclitaxel Albumin Bound Regimen • Breast – Atezolizumab-Paclitaxel Al
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Atezolizumab-Paclitaxel-Albumin-Bound.pdf

GDP-Cisplatin-Dexamethasone-Gemcitabine

Description: Chemotherapy Protocol LYMPHOMA CISPLATIN-DEXAMETHASONE-GEMCITABINE (GDP) Regimen • Lymphoma – GDP-Cisplatin-De
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/GDP-Cisplatin-Dexamethasone-Gemcitabine.pdf

RGDP-Cisplatin-Dexamethasone-Gemcitabine-Rituximab

Description: Chemotherapy Protocol LYMPHOMA CISPLATIN-DEXAMETHASONE-GEMCITABINE-RITUXIMAB (RGDP) Regimen • Lymp
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RGDP-Cisplatin-Dexamethasone-Gemcitabine-Rituximab.pdf

IRD(40)-Dexamethasone_40_Ixazomib-Lenalidomide

Description: Chemotherapy Protocol Myeloma IRD (40) - Dexamethasone (40)-Ixazomib-Lenalidomide Regimen • Myeloma – IRD (40)
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/IRD40-Dexamethasone-40-Ixazomib-Lenalidomide.pdf

IRD(20)-Dexamethasone_20_Ixazomib-Lenalidomide

Description: Chemotherapy Protocol Myeloma IRD (20) - Dexamethasone (20)-Ixazomib-Lenalidomide Regimen • Myeloma – IRD (20)
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/IRD20-Dexamethasone-20-Ixazomib-Lenalidomide.pdf

Docetaxel-Nintedanib v1

Description: Chemotherapy Protocol NSCLC CANCER DOCETAXEL-NINTEDANIB Regimen NSCLC – Docetaxel-Nintedanib Indication Advanced or metastati
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxel-Nintedanib-v1.pdf

DA_3+8_CADD

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA Ambulatory Regimen AmB - DA (3+8) CADD–Cytarabine-Daunorubic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-3-8-CADD.pdf

WRES report and action plan 2023

Description: Workforce Race Equality Standard Annual Report 2023 1 Table of Contents Executive Summary..........................................................................
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/WRES-report-and-action-plan-2023.pdf

WDES annual report 2022

Description: Workforce Disability Equality Standard - Annual Report 2022 2 Executive Summary The Workforce Disability Equality Standard (W
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/Workforce-Disability-Equality-Standard-Annual-Report-2022.docx

1 to 10 of 452

Previous 1 2 3 4 5 … Next